证券代码：839273 证券简称：一致魔芋 公告编号：2025-070 湖北一致魔芋生物科技股份有限公司 关于完成工商变更及公司章程备案并取得营业执照的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、基本情况 湖北一致魔芋生物科技股份有限公司（以下简称"公司"）分别于 2025 年 4 月 26 日、2025 年 5 月 13 日召开第三届董事会第二十三次会议和 2025 年第二 次临时股东会，审议并通过《关于拟变更注册资本、修订<公司章程>并办理工商 变更登记的议案》，具体内容详见公司分别于 2025 年 4 月 28 日和 2025 年 5 月 14 日在北京证券交易所指定信息披露平台（www.bse.cn）披露的《关于拟变更 公司注册资本及修订<公司章程>并办理工商变更登记的公告》（公告编号： 2025-061）、《公司章程》（公告编号：2025-068）。 目前，公司已完成工商变更登记及公司章程备案手续并取得变更后的《营业 执 照 》 。 本 次 变 更 完 成 后 ， 公 司 注 册 ...

Group 1 - The A-share pet economy sector is experiencing a downturn, with companies such as Meino Biological and Tianyuan Pet falling over 7% [1] - Yuanfei Pet has seen a decline of nearly 4%, while other companies like Yizhi Mogu and Hasan Lian are also following the downward trend [1]

Summary of the Conference Call on the Konjac Industry and Yizhi Konjac Company Industry Overview - The konjac planting area in China is approximately 2 million acres in 2025, mainly distributed in Yunnan, Guizhou, and Sichuan provinces, often in intercropping patterns [2][4][5] - The konjac plant requires specific altitude and climate conditions, typically growing in mountainous areas, with a growth cycle that can last up to five years [2][6][7] - The market for konjac, particularly in health food sectors, is expanding due to its recognized health benefits, including weight loss and cholesterol reduction [2][12] Company Profile - Yizhi Konjac is a leading enterprise in the konjac industry, with two subsidiaries and a chairman recognized as a national talent [2][10] - The company has maintained a net asset return rate of approximately 12.3% over the past three years, with a post-listing price-to-earnings ratio of 27 times and a price-to-book ratio of 3.79 times [2][10] - In 2024, the company reported revenue of 617 million yuan and a net profit of 86.7 million yuan, with a significant increase in Q1 2025 revenue to 150 million yuan and net profit of 22.7 million yuan [4][15] Market Dynamics - The price of konjac raw materials increased by approximately 80% in 2024, affecting cash flow due to rising procurement costs [4][17][15] - The demand for konjac-related food ingredients surged in 2024, driven by health trends and the popularity of brands using konjac as a raw material [3][27] - The planting area is expected to increase by 10% to 15% in 2025, but adverse weather conditions could impact overall yield [28] Product and Application - Yizhi Konjac focuses on mid-to-late stage technology research and development, deep processing, and brand operation, with products including konjac hydrophilic colloids, konjac foods, and beauty products [2][10][13] - The company is recognized for its global sales leadership in purified konjac powder and collaborates with several well-known enterprises [2][10][14] - The konjac powder has a shelf life of 18 months, while finished products can last up to 24 months [19] Future Strategy - The company aims to expand its market share in health foods and enhance its product offerings, focusing on the extraction of glucomannan from konjac [16][32] - Future growth is expected to be driven by deep processing trends, increasing market concentration, and enhanced trade acceptance [16] - The company plans to strengthen its research and development capabilities and expand into new product categories, including jelly, pudding, and health supplements [16] Competitive Landscape - Yizhi Konjac holds a significant position in the global market, with an annual production capacity of 10,200 tons, accounting for approximately 12% of global sales [22] - The company faces competition from other domestic firms, but the top three companies collectively hold over 20% of the global market share [22] Conclusion - The konjac industry is poised for growth, driven by health trends and increasing consumer awareness. Yizhi Konjac is strategically positioned to capitalize on these trends through innovation and market expansion efforts [2][10][16]

Group 1: Investor Relations Activities - The company conducted investor relations activities from May 15 to May 19, 2025, including a network meeting with specific investors [3][4] - Participating institutions included major financial entities such as Goldman Sachs, Morgan Stanley, and HSBC Global Asset Management [4] Group 2: Market Distribution and Applications - The company's konjac powder is exported to over 40 countries, primarily in Southeast Asia, Europe, and Russia, used in jelly, health products, animal nutrition, and meat production [4][5] - The company is actively expanding into the South American market [4] Group 3: Seasonal Revenue Trends - Revenue is primarily concentrated in Q3 and Q4 due to market consumption patterns, with strong demand during festivals like Mid-Autumn and National Day [5] Group 4: Brand and ODM Development - The company focuses on B2B operations, with its own brand "Molege" showing an upward trend through online and local tourism channels [6] - ODM client cooperation remains stable, with overall business growth [6] Group 5: Production Capacity and Expansion Plans - Current production capacities include 10,000 tons for konjac snacks, 15,000 tons for konjac ingredients, and 3.5 tons for konjac balls [7] - Ongoing projects include a konjac gel intelligent manufacturing facility expected to reach production in June 2025, and an 80,000-ton konjac tea ingredient workshop under construction [7] Group 6: Future Business Planning - The company plans to increase investment in application and product research and development to explore new applications and functions of konjac gel [8][9] Group 7: Industry Competition Trends - The konjac industry is niche but competitive, with trends indicating a shift towards deep processing, increasing market concentration, and growing acceptance of konjac products [10]

Group 1 - In the past month (from April 16 to May 15), 39 companies listed on the Beijing Stock Exchange (BSE) were investigated by institutions, with Yizhi Mogu being the most popular, receiving attention from 78 institutions [1] - The types of institutions conducting the research included 39 brokerages, 33 funds, 27 private equity firms, 19 insurance companies, and 5 overseas institutions [1] - The companies that received the most attention after Yizhi Mogu were Litong Technology, Kangbiter, and Jikang Instruments, with 75, 73, and 50 institutions participating in their investigations, respectively [1] Group 2 - The average stock price of the companies investigated by institutions increased by 10.33% over the past month, with 32 stocks rising, including Guohang Ocean, Jinbo Biological, and Lintai New Materials, which saw increases of 78.12%, 28.19%, and 26.01% respectively [2] - The average daily turnover rate for the investigated companies was 8.38%, with the highest turnover rates recorded for Wanda Bearings, Taihu Snow, and Lintai New Materials at 24.09%, 20.70%, and 17.40% respectively [2] - As of May 15, the average market capitalization of all companies on the BSE was 3.071 billion yuan, while the average market capitalization of the investigated companies was 4.820 billion yuan [2] Group 3 - The table lists various companies along with the number of institutions that investigated them, the number of investigations, latest closing prices, percentage changes, and their respective industries [3] - Notable companies include Yizhi Mogu with 78 institutions and a price increase of 17.17%, Litong Technology with 75 institutions and a price increase of 22.84%, and Jinbo Biological with 23 institutions and a price increase of 28.19% [3]

Group 1 - The pet economy concept rose by 1.98%, ranking third among concept sectors, with 54 stocks increasing in value, including major gainers like Meino Biological and Jieya Co., which hit the 20% limit up [1][2] - Notable stocks with significant increases include Xianle Health, Huisheng Biological, and Yiyuan Magic Yam, which rose by 13.41%, 10.50%, and 9.10% respectively [1] - The leading decliners in the sector were Zhiou Technology, Qingmu Technology, and Yingstone Network, which fell by 4.64%, 4.42%, and 2.73% respectively [1] Group 2 - The pet economy sector saw a net inflow of 236 million yuan, with 48 stocks receiving net inflows, and 7 stocks attracting over 30 million yuan each [2] - The top stock for net inflow was Yong'an Pharmaceutical, with a net inflow of 68.36 million yuan, followed by Jieya Co., Ruoyuchen, and Meino Biological with net inflows of 48.24 million yuan, 46.14 million yuan, and 45.47 million yuan respectively [2][3] Group 3 - In terms of net inflow ratios, Jieya Co., Jiabiyou, and Meino Biological led with net inflow rates of 27.98%, 13.31%, and 11.04% respectively [3] - The pet economy sector's inflow ranking included stocks like Yong'an Pharmaceutical, Jieya Co., Ruoyuchen, and Meino Biological, all showing strong performance in terms of trading volume and turnover rates [3][4]

Group 1 - The core viewpoint of the article highlights the significant rise in food stocks, particularly noting that Xiwang Food has reached its daily limit increase [1] - Xiwang Food has experienced a limit increase, while other companies such as Yizhi Magic Tofu have risen over 10%, and companies like Kangbiter, Ximai Food, Knight Dairy, and Andeli have all seen increases of over 5% [1]

湖北一致魔芋生物科技股份有限公司 章 程 2025 年 5 月 1 | 目 | 录 2 | | --- | --- | | 第一章 | 总则 4 | | 第二章 | 经营宗旨和范围 5 | | 第三章 | 股份 5 | | 第一节 | 股份发行 5 | | 第二节 | 股份增减和回购 6 | | 第三节 | 股份转让 8 | | 第四章 | 股东和股东大会 9 | | 第一节 | 股东 9 | | 第二节 | 股东大会的一般规定 11 | | 第三节 | 股东大会的召集 13 | | 第四节 | 股东大会的提案与通知 14 | | 第五节 | 股东大会的召开 16 | | 第六节 | 股东大会的表决和决议 19 | | 第五章 | 董事会 25 | | 第一节 | 董事 25 | | 第二节 | 董事会 35 | | 第三节 | 董事会秘书 40 | | 第六章 | 经理及其他高级管理人员 41 | | 第七章 | 监事会 43 | | 第一节 | 监事 43 | | 第二节 | 监事会 44 | | 第八章 | 重大交易与关联交易 46 | | 第一节 | 重大交易 46 | | 第二节 | 关联交易 51 ...

证券代码：839273 证券简称：一致魔芋 公告编号：2025-066 湖北一致魔芋生物科技股份有限公司 2025 年第二次临时股东会决议公告 （一）会议召开情况 1.会议召开时间：2025 年 5 月 13 日 2.会议召开地点：湖北长阳经济开发区长阳大道 438 号公司二楼会议室 3.会议召开方式：本次会议采用现场投票和网络投票相结合方式召开 4.会议召集人：董事会 5.会议主持人：董事长吴平女士 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （二）会议出席情况 出席和授权出席本次股东会的股东共 11 人，持有表决权的股份总数 54,258,431 股，占公司有表决权股份总数的 52.67%。 其中通过网络投票参与本次股东会的股东共 3 人，持有表决权的股份总数 12,573,851 股，占公司有表决权股份总数的 12.21%。 （三）公司董事、监事、高级管理人员出席或列席股东会情况 1.公司在任董事 9 人，出席 9 人； 6.召开情况合法合规的说明： 本次会议的召集、召 ...

湖北陈守邦律师事务所 关于湖北一致魔芋生物科技股份有限公司 2025 年第二次临时股东会的法律意见书 湖北陈守邦律师事 CHENSHOUBANG LAWFIRM HUBEI 地址：湖北省宜昌市发展大道 57-6 号三峡云计算中心 B 座 17 层 电话:0717-6900007 邮编: 443005 1 湖北陈守邦律师事务所 法律意见书 湖北陈守邦律师事务所 致:湖北一致魔芋生物科技股份有限公司 湖北陈守邦律师事务所（以下简称"本所"）接受湖北一致魔芋生物科技股 份有限公司（以下简称"公司"）的委托,根据《中华人民共和国公司法》(以下 简称"《公司法》")、《中华人民共和国证券法》(以下简称"《证券法》") 等法律、 法规、规章和规范性文件以及《湖北一致魔芋生物科技股份有限公司章程》(以 下简称"《公司章程》"）的相关规定，指派律师列席公司 2025 年第二次临时股东 会(以下简称"本次股东会"),对本次股东会相关事项进行见证,并依法出具本 法律意见书。 本法律意见书仅就本次股东会的召集和召开程序、出席本次股东会现场会议 人员的资格、召集人资格、表决程序及表决结果发表意见,而不对本次股东会所 审议的议案内容以 ...